<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33486795</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2230</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental dermatology</Title>
          <ISOAbbreviation>Clin Exp Dermatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Identification of clinically useful predictive genetic variants in pachyonychia congenita.</ArticleTitle>
        <Pagination>
          <StartPage>867</StartPage>
          <EndPage>873</EndPage>
          <MedlinePgn>867-873</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ced.14569</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pachyonychia congenita (PC) refers to a group of autosomal dominant disorders caused by mutations in five keratin genes (KRT16,KRT6A,KRT17,KRT6B or KRT6C). Current disease classification is based on the gene harbouring disease-causing variants.</AbstractText>
          <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">We harnessed the International Pachyonychia Congenita Research Registry (IPCRR) containing both clinical and molecular data on patients with PC worldwide, to identify genetic variants predicting disease severity.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We ascertained 815 individuals harbouring keratin mutations registered in the IPCRR. We looked for statistically significant associations between genetic variants and clinical manifestations in a subgroup of patients carrying mutations found in at least 10% of the cohort. Data were analysed using χ<sup>2</sup> and Kruskal-Wallis tests.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified five mutations occurring in at least 10% of the patients registered in the IPCRR. The KRT16 p.L132P mutation was significantly associated with younger age of onset, presence of palmar keratoderma oral leucokeratosis and a higher number of involved nails. By contrast, the KRT16 p.N125S and p.R127C mutations resulted in a milder phenotype featuring a decreased number of involved nails and older age of onset. Patients carrying the p.N125S mutation were less likely to develop palmar keratoderma while p.R127C was associated with an older age of palmoplantar keratoderma onset. Moreover, the KRT17 p.L99P mutation resulted in an increased number of involved fingernails and patients demonstrating 20-nail dystrophy, while the opposite findings were observed with KRT17 p.N92S mutation.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We have identified novel and clinically useful genetic predictive variants in the largest cohort of patients with PC described to date.</AbstractText>
          <CopyrightInformation>© 2021 British Association of Dermatologists.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Samuelov</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0001-5387-5490</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sarig</LastName>
            <ForeName>O</ForeName>
            <Initials>O</Initials>
            <Identifier Source="ORCID">0000-0003-2987-2091</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adir</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Schulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pavlovsky</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>F J</ForeName>
            <Initials>FJ</Initials>
            <AffiliationInfo>
              <Affiliation>Pachyonychia Congenita Project, Holladay, UT, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schwartz</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Pachyonychia Congenita Project, Holladay, UT, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hansen</LastName>
            <ForeName>C D</ForeName>
            <Initials>CD</Initials>
            <AffiliationInfo>
              <Affiliation>Pachyonychia Congenita Project, Holladay, UT, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University of Utah, Salt Lake City, UT, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sprecher</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>03</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Clin Exp Dermatol</MedlineTA>
        <NlmUniqueID>7606847</NlmUniqueID>
        <ISSNLinking>0307-6938</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C507431">KRT16 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C000629088">KRT17 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C507569">KRT6A protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C507570">KRT6B protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C507571">KRT6C protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053536">Keratin-16</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053537">Keratin-17</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053553">Keratin-6</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>68238-35-7</RegistryNumber>
          <NameOfSubstance UI="D007633">Keratins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C562907">Twenty-Nail Dystrophy</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053536" MajorTopicYN="N">Keratin-16</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053537" MajorTopicYN="N">Keratin-17</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053553" MajorTopicYN="N">Keratin-6</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007633" MajorTopicYN="N">Keratins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007645" MajorTopicYN="N">Keratoderma, Palmoplantar</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007642" MajorTopicYN="N">Keratosis</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007972" MajorTopicYN="N">Leukoplakia, Oral</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009260" MajorTopicYN="N">Nail Diseases</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009264" MajorTopicYN="N">Nails, Malformed</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053549" MajorTopicYN="N">Pachyonychia Congenita</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>24</Day>
          <Hour>20</Hour>
          <Minute>54</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33486795</ArticleId>
        <ArticleId IdType="doi">10.1111/ced.14569</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>McLean WH, Rugg EL, Lunny DP et al. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet 1995; 9: 273-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Eliason MJ, Leachman SA, Feng BJ et al. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol 2012; 67: 680-6.</Citation>
        </Reference>
        <Reference>
          <Citation>Bowden PE, Haley JL, Kansky A et al. Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nat Genet 1995; 10: 363-5.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith FJ, Liao H, Cassidy AJ et al. The genetic basis of pachyonychia congenita. J Invest Dermatol Symp Proc 2005; 10: 21-30.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith FJD, Hansen CD, Hull PR et al. Pachyonychia congenita. In: GeneReviews® (Adam MP, Ardinger HH, Pagon RA et al., eds). Seattle: University of Washington, 1993.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson NJ, Messenger AG, Leachman SA et al. Keratin K6c mutations cause focal palmoplantar keratoderma. J Invest Dermatol 2010; 130: 425-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Feinstein A, Friedman J, Schewach-Millet M. Pachyonychia congenita. J Am Acad Dermatol 1988; 19: 705-11.</Citation>
        </Reference>
        <Reference>
          <Citation>Paller AS, Moore JA, Scher R. Pachyonychia congenita tarda. A late-onset form of pachyonychia congenita. Arch Dermatol 1991; 127: 701-3.</Citation>
        </Reference>
        <Reference>
          <Citation>Stieglitz JB, Centerwall WR. Pachyonychia congenita (Jadassohn-Lewandowsky syndrome): a seventeen-member, four-generation pedigree with unusual respiratory and dental involvement. Am J Med Genet 1983; 14: 21-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Su WP, Chun SI, Hammond DE, Gordon H. Pachyonychia congenita: a clinical study of 12 cases and review of the literature. Pediatr Dermatol 1990; 7: 33-8.</Citation>
        </Reference>
        <Reference>
          <Citation>McLean WH, Hansen CD, Eliason MJ, Smith FJ. The phenotypic and molecular genetic features of pachyonychia congenita. J Invest Dermatol 2011; 131: 1015-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Feng YG, Xiao SX, Ren XR et al. Keratin 17 mutation in pachyonychia congenita type 2 with early onset sebaceous cysts. Br J Dermatol 2003; 148: 452-5.</Citation>
        </Reference>
        <Reference>
          <Citation>Samuelov L, Smith FJD, Hansen CD, Sprecher E. Revisiting pachyonychia congenita: a case-cohort study of 815 patients. Br J Dermatol 2020; 182: 738-46.</Citation>
        </Reference>
        <Reference>
          <Citation>Mezulis S, Sternberg MJE, Kelley LA. PhyreStorm: a web server for fast structural searches against the PDB. J Mol Biol 2016; 428: 702-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Ahn J, Jo I, Kang SM et al. Structural basis for lamin assembly at the molecular level. Nat Commun 2019; 10: 3757.</Citation>
        </Reference>
        <Reference>
          <Citation>Fu T, Leachman SA, Wilson NJ et al. Genotype-phenotype correlations among pachyonychia congenita patients with K16 mutations. J Invest Dermatol 2011; 131: 1025-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Shamsher MK, Navsaria HA, Stevens H et al. Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. Hum Mol Genet 1995; 4: 1875-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Connors JB, Rahil AK, Smith FJ et al. Delayed-onset pachyonychia congenita associated with a novel mutation in the central 2B domain of keratin 16. Br J Dermatol 2001; 144: 1058-62.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith FJ. Nail that mutation-keratin 17 defect in late-onset pachyonychia. J Invest Dermatol 2004; 122: x-xi.</Citation>
        </Reference>
        <Reference>
          <Citation>Xiao SX, Feng YG, Ren X et al. A novel mutation in the second half of the keratin 17 1A domain in a large pedigree with delayed-onset pachyonychia congenita type 2. J Invest Dermatol 2004; 122: 892-5.</Citation>
        </Reference>
        <Reference>
          <Citation>McLean WH, Smith FJ, Cassidy AJ. Insights into genotype-phenotype correlation in pachyonychia congenita from the human intermediate filament mutation database. J Invest Dermatol Symp Proc 2005; 10: 31-6.</Citation>
        </Reference>
        <Reference>
          <Citation>Sybert VP, Francis JS, Corden LD et al. Cyclic ichthyosis with epidermolytic hyperkeratosis: a phenotype conferred by mutations in the 2B domain of keratin K1. Am J Hum Genet 1999; 64: 732-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Terron-Kwiatkowski A, Terrinoni A, Didona B et al. Atypical epidermolytic palmoplantar keratoderma presentation associated with a mutation in the keratin 1 gene. Br J Dermatol 2004; 150: 1096-103.</Citation>
        </Reference>
        <Reference>
          <Citation>Bochner R, Samuelov L, Sarig O et al. Calpain 12 function revealed through the study of an atypical case of autosomal recessive congenital ichthyosis. J Invest Dermatol 2017; 137: 385-93.</Citation>
        </Reference>
        <Reference>
          <Citation>Sussmuth K, Gruber R, Rodriguez E et al. Increased prevalence of filaggrin deficiency in 51 patients with recessive X-linked ichthyosis presenting for dermatological examination. J Invest Dermatol 2018; 138: 709-11.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
